Delivery Order SPE2DB22D3401-SPE2DB25FT2WJ

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $2,904.43, is for the delivery of RECTIV 0.4% ointment 30GM to support federal healthcare programs. The contract has an ultimate completion date of December 10, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award is for the delivery of Rectiv 0.4% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. The contract has a ceiling value of $6,011.76 and a completion date of July 7, 2023. This contract does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4562283859 RECTIV 0.4% OINTMENT 30GM. The $1,916.34 fixed-price Delivery Order contract has a completion date of September 25, 2023. This contract is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,005.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RECTIV 0.4% ointment, a medical product, with a completion date of December 20, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.55, is a delivery order for 4567175522 RECTIV 0.4% OINTMENT 30GM. It is a firm-fixed price contract with a completion date of February 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.50 firm-fixed-price delivery order is for the supply of 4566597198 RECTIV 0.4% OINTMENT 30GM. The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, RECTIV 0.4% Ointment 30GM. The $3,705.96 contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This federal contract award is for the delivery of RECTIV 0.4% ointment in 30 gram units to the Defense Logistics Agency (DLA). The $1,125.26 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. No set-aside designation was used. Amerisourcebergen Drug Corp has an established history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,506.07 Firm Fixed Price delivery order contract is for the provision of RECTIV 0.4% ointment, a medical product, with a period of performance through February 12, 2025. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564885184 RECTIV 0.4% OINTMENT 30GM to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $1,958.04 and an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2WJ
    Delivery Order

This federal contract award is for the delivery of 0.4% RECTIV ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,525.37, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/24/25, 9:47 AM